C WorldWide Group Holding A/S
Position in KPTI — Karyopharm Therapeutics Inc.
CIK 1625244
COPENHAGEN, G7
Position in KPTI
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$977,000
+$420,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 96 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KPTI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026C WorldWide Group Holding A/S holds $185,739,264 across 13 Biotechnology names. KPTI ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
366,000 | $29,020,140 | |
| 2 | INSM |
INSMED Inc
|
261,110 | $27,839,548 | |
| 3 | RPRX |
Royalty Pharma plc
|
471,881 | $26,458,367 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
46,057 | $22,877,893 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
57,809 | $21,485,871 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
267,851 | $15,326,434 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
195,000 | $11,335,350 | |
| 8 | ZLAB |
Zai Lab Ltd
|
510,000 | $9,690,000 |
All Filings in KPTI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,000 | 100,000 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $557,000 | 100,000 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $736,000 | 100,000 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $654,000 | 100,000 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $431,000 | 100,000 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $374,000 | 100,000 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $1,014,000 | 1,500,000 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,245,000 | 1,500,000 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $1,302,000 | 1,500,000 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $2,265,000 | 1,500,000 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $1,297,500 | 1,500,000 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $2,010,000 | 1,500,000 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $2,685,000 | 1,500,000 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $5,835,000 | 1,500,000 | Shares | Defined | 2023-05-02 | |
| 2022-12-31 | $5,100,000 | 1,500,000 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $8,190,000 | 1,500,000 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $6,765,000 | 1,500,000 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $11,055,000 | 1,500,000 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $9,645,000 | 1,500,000 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $6,984,000 | 1,200,000 | Shares | Defined | 2021-11-01 | |
| 2021-06-30 | $12,384,000 | 1,200,000 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $12,624,000 | 1,200,000 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $9,288,000 | 600,000 | Shares | Defined | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||